NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $182,774 | +25.2% | 25,245 | +77.7% | 0.04% | -2.2% |
Q4 2022 | $146,027 | -48.2% | 14,205 | -8.9% | 0.04% | -48.9% |
Q3 2022 | $282,000 | -74.6% | 15,590 | -27.9% | 0.09% | -74.4% |
Q2 2022 | $1,112,000 | -24.0% | 21,626 | +8.9% | 0.34% | -6.8% |
Q1 2022 | $1,463,000 | -48.9% | 19,863 | -0.7% | 0.37% | -43.4% |
Q4 2021 | $2,861,000 | -29.8% | 20,000 | -3.2% | 0.65% | -34.1% |
Q3 2021 | $4,077,000 | -7.1% | 20,667 | -4.5% | 0.99% | -4.9% |
Q2 2021 | $4,390,000 | +9.7% | 21,647 | -5.8% | 1.04% | -1.2% |
Q1 2021 | $4,002,000 | +52.7% | 22,974 | -2.3% | 1.05% | +27.3% |
Q4 2020 | $2,621,000 | -2.9% | 23,508 | -5.6% | 0.83% | -15.7% |
Q3 2020 | $2,699,000 | -11.0% | 24,906 | -34.6% | 0.98% | -13.8% |
Q2 2020 | $3,033,000 | +439.7% | 38,059 | -8.0% | 1.14% | +341.5% |
Q1 2020 | $562,000 | +284.9% | 41,359 | +12.0% | 0.26% | +855.6% |
Q4 2019 | $146,000 | +40.4% | 36,918 | +78.5% | 0.03% | -42.6% |
Q3 2019 | $104,000 | -42.2% | 20,686 | -32.6% | 0.05% | -42.7% |
Q2 2019 | $180,000 | – | 30,711 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |